Alfonso Gomez-Iturriaga

6PUBLICATIONS
32CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
Outcomes of Radiotherapy With or Without Dose Escalation to Lymph Node Metastases Detected by PET PSMA or Conventional Imaging in Node-Positive Prostate Cancer: A Real-World Multicenter Propensity Score-Matched (PRIMENOD) Analysis.

|Oct 16, 2025
Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations.

Aránzazu González-Del-Alba, Claudio Martínez Ballesteros, José Ángel Arranz

|Aug 28, 2025
Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate Cancer.

Victor Duque-Santana, Julio Fernandez, Fernando López-Campos

|Mar 13, 2025
Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer.

Victor Duque-Santana, Julio Fernandez, Ana Diaz-Gavela

|Feb 11, 2024
Criteria and indicators to evaluate quality of care in genitourinary tumour boards.

Javier Puente, Ferrán Algaba Arrea, Óscar Buisán Rueda

|May 23, 2019
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT.

Alfonso Gomez-Iturriaga, Francisco Casquero Ocio, Piet Ost

Pageof 1

Frequent Collaborators

3 joint publications

Fernando López-Campos

2 joint publications

Felipe Couñago

2 joint publications

Thomas Zilli

2 joint publications

Elia Del Cerro